Journal of cardiovascular electrophysiology · 2026
Same-Day Discharge in Ventricular Ablation: Safety Outcomes and Case Selection.
СтатьяНаблюдательное исследованиеСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xie Eric, Viola Jody, Ness Sydney, Pokorney Sean D, Hegland Donald D, Friedman Daniel J, Jackson Kevin P, Piccini Jonathan P, Koontz Jason I, Sun Albert Y, Duke Ventricular Arrhythmia Group
Аннотация
INTRODUCTION: Catheter ablation (CA) of ventricular arrhythmias (VA) has traditionally entailed an overnight stay, and little has been published on outcomes of same-day discharge (SDD) in this population. Thus far, no comparative study of SDD in VA ablation has been described.
METHODS: This was a single-center prospective comparative observational study of 255 consecutive patients undergoing elective CA of VA (PVC or VT) in the outpatient setting between April 2023 and June 2025. We excluded patients who were pre-admitted or planned for admission or overnight stays post-ablation. SDD was at the attending physician's discretion. Post-discharge, patients had routine telephone follow-up to monitor for complications.
RESULTS: Among 255 patients undergoing ablation for ventricular arrhythmia, 123 (48%) underwent SDD. Patients undergoing SDD had a mean age of 61 ± 16, 38% were female, 33% had heart failure, and the majority had CA for PVC (96%). Compared with those who stayed overnight, SDD patients had higher EF (50% vs. 46%, p = 0.003), less arterial access (48% vs. 62%, p = 0.02), and lower PAINESD score (3.4 vs. 4.8, p = 0.04). Over 30 days of follow-up, two patients (1.6%) had major access site complications, and one (0.8%). Based upon these observations, we describe favorable characteristics for SDD in CA of VA, with the key features of including low-to-moderate risk patients, early case timing, liberal closure device usage, and close follow-up by a dedicated clinical nurse.
CONCLUSION: SDD is feasible and safe for patients undergoing PVC ablation and potentially a subset of patients undergoing VT ablation.
METHODS: This was a single-center prospective comparative observational study of 255 consecutive patients undergoing elective CA of VA (PVC or VT) in the outpatient setting between April 2023 and June 2025. We excluded patients who were pre-admitted or planned for admission or overnight stays post-ablation. SDD was at the attending physician's discretion. Post-discharge, patients had routine telephone follow-up to monitor for complications.
RESULTS: Among 255 patients undergoing ablation for ventricular arrhythmia, 123 (48%) underwent SDD. Patients undergoing SDD had a mean age of 61 ± 16, 38% were female, 33% had heart failure, and the majority had CA for PVC (96%). Compared with those who stayed overnight, SDD patients had higher EF (50% vs. 46%, p = 0.003), less arterial access (48% vs. 62%, p = 0.02), and lower PAINESD score (3.4 vs. 4.8, p = 0.04). Over 30 days of follow-up, two patients (1.6%) had major access site complications, and one (0.8%). Based upon these observations, we describe favorable characteristics for SDD in CA of VA, with the key features of including low-to-moderate risk patients, early case timing, liberal closure device usage, and close follow-up by a dedicated clinical nurse.
CONCLUSION: SDD is feasible and safe for patients undergoing PVC ablation and potentially a subset of patients undergoing VT ablation.